Reaction

Crest Syndrome reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 235 reports · 5 co-occurring drugs

As of the last recalculation, Crest Syndrome appears in 235 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is EPOPROSTENOL (PRR 56.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Epoprostenol856.056.0
Selexipag1554.954.9
Macitentan3043.843.9
Bosentan1834.234.2
Ambrisentan3327.127.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.